Re: Chicharros USA - bolsa internacional
SPHS
"Given the very conservative combined revenue of $119 million a year, factoring in the costs, time, and effort of bringing the drugs through FDA approval and to the market, I believe we can easily receive a buyout multiple between 3 and 4 times this amount. A $357-$476 million aggregate cash buyout would equal $17.15-$22.86 per share with 20.82 million shares outstanding. At the time this article was written SPHS was priced at $5.31 per share."
Donde hay que firmar??